T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortinet
FTNT
|
+$2.03B |
| 2 |
Rockwell Automation
ROK
|
+$1.44B |
| 3 |
Autodesk
ADSK
|
+$1.15B |
| 4 |
Citigroup
C
|
+$975M |
| 5 |
ConocoPhillips
COP
|
+$967M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.59B |
| 2 |
GE Aerospace
GE
|
+$1.78B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.38B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.08B |
| 5 |
Philip Morris
PM
|
+$1.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.21% |
| 2 | Healthcare | 15.42% |
| 3 | Financials | 10.99% |
| 4 | Consumer Discretionary | 10.39% |
| 5 | Communication Services | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Otis Worldwide
OTIS
$27.9B
| $225M | 0.03% |
2,265,249
-385,907
| -15% | -$35.7M |
|
402
Kanzhun
BZ
$6.84B
| $225M | 0.03% |
12,814,379
-1,068,719
| -8% | -$16.9M |
|
403
IQVIA
IQV
$39.5B
| $224M | 0.03% |
886,948
+60,079
| +7% | +$14M |
|
404
Vale
VALE
$59B
| $223M | 0.03% |
18,290,720
-3,995,975
| -18% | -$53.9M |
|
|
DOCU
405
DocuSign
DOCU
$11.3B
| $221M | 0.03% |
3,712,259
-4,276,351
| -54% | -$241M |
|
406
Domino's
DPZ
$11.6B
| $221M | 0.03% |
444,780
+230,090
| +107% | +$99.9M |
|
407
Aon
AON
$74.8B
| $220M | 0.03% |
658,409
-222,331
| -25% | -$68.9M |
|
408
Royal Caribbean
RCL
$82.7B
| $219M | 0.03% |
1,577,752
-9,562
| -0.6% | -$1.19M |
|
409
CMS Energy
CMS
$22.1B
| $218M | 0.03% |
3,619,975
-1,634,885
| -31% | -$94.8M |
|
410
Vaxcyte
PCVX
$8.87B
| $217M | 0.03% |
3,176,181
+498,359
| +19% | +$34.5M |
|
411
Madrigal Pharmaceuticals
MDGL
$11.9B
| $214M | 0.03% |
803,213
+414,484
| +107% | +$97.7M |
|
412
SBA Communications
SBAC
$19.8B
| $214M | 0.03% |
986,487
+33,507
| +4% | +$7.45M |
|
413
Morningstar
MORN
$7.49B
| $211M | 0.03% |
684,743
-26,889
| -4% | -$7.75M |
|
414
Dentsply Sirona
XRAY
$2.27B
| $208M | 0.03% |
6,266,781
+343,915
| +6% | +$11.7M |
|
415
Teck Resources
TECK
$31.2B
| $206M | 0.03% |
4,501,078
+662,383
| +17% | +$26.6M |
|
416
Cytokinetics
CYTK
$10.3B
| $205M | 0.03% |
2,930,948
-313,302
| -10% | -$24.2M |
|
417
ScottsMiracle-Gro
SMG
$3.58B
| $203M | 0.02% |
2,726,338
+542,406
| +25% | +$33.7M |
|
|
SWTX
418
DELISTED
SpringWorks Therapeutics
SWTX
| $202M | 0.02% |
4,110,462
+1,333,892
| +48% | +$61.7M |
|
419
Lockheed Martin
LMT
$138B
| $201M | 0.02% |
442,850
-24,329
| -5% | -$10.7M |
|
420
Li Auto
LI
$12B
| $201M | 0.02% |
6,627,468
+83,656
| +1% | +$2.77M |
|
421
Trade Desk
TTD
$6.54B
| $199M | 0.02% |
2,279,299
-4,366,266
| -66% | -$331M |
|
422
Gartner
IT
$11.1B
| $198M | 0.02% |
414,559
+114,610
| +38% | +$52.7M |
|
423
Amcor
AMCR
$21.5B
| $196M | 0.02% |
4,120,832
+417,340
| +11% | +$19.5M |
|
|
SWAV
424
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $195M | 0.02% |
598,200
-186,769
| -24% | -$45.9M |
|
425
Targa Resources
TRGP
$57.8B
| $195M | 0.02% |
1,738,721
+360,675
| +26% | +$34M |
|
Similar funds
T. Rowe Price Associates's Q1 2024 Portfolio in Review
As of Q1 2024, T. Rowe Price Associates held 3,021 positions worth $816B, up 9.6% from $744B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q1 2024 filing shows 108 new, 1,941 increased, 738 reduced and 64 closed positions. Its largest new stake was GE Vernova: 2,687,194 shares worth $367M. The largest sale was NVIDIA, an estimated $2.59B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2024 buy was GE Vernova: 2,687,194 shares worth $367M.
- T. Rowe Price Associates added most to Fortinet in Q1 2024, an estimated $2.03B increase.
- T. Rowe Price Associates's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $2.59B.
- T. Rowe Price Associates fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $621M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $816B portfolio in Q1 2024.
- T. Rowe Price Associates opened 108 new positions and closed 64 in Q1 2024.
- T. Rowe Price Associates's portfolio value rose 9.6% quarter-over-quarter to $816B.
Based on T. Rowe Price Associates's 13F filing for Q1 2024, filed 15 May 2024.